Akero Therapeutics, Inc

(NASDAQ:AKRO)

Latest On Akero Therapeutics, Inc (AKRO):

Date/Time Type Description Signal Details
2023-05-18 02:59 ESTNewsAkero Therapeutics: A Promising Solution For NASH Patients And InvestorsN/A
2023-05-17 13:48 ESTNewsAkero Therapeutics prices $220M offeringN/A
2023-05-15 20:39 ESTNewsAkero Therapeutics GAAP EPS of -$0.55N/A
2023-05-09 09:17 ESTNewsAkero Therapeutics: Proof Of Concept With EFX, Sets Up Catalyst Opportunities In 2023N/A
2023-05-07 19:00 ESTNewsAkero Therapeutics: Excellent Data, Solid Clinical Potential, No Major Near Term CatalystsN/A
2023-03-30 00:33 ESTNewsAkero plans to begin Phase 3 trial of NASH treatment in H2 after successful FDA meetN/A
2023-03-17 20:34 ESTNewsAkero Therapeutics GAAP EPS of -$0.49 beats by $0.31N/A
2023-02-08 18:19 ESTNewsAkero Therapeutics: NASH Differentiator Attractive, Awaiting Additional Price CatalystsN/A
2023-01-27 18:31 ESTNewsAkero upgraded at Morgan Stanley on NASH prospectsN/A
2022-12-08 21:25 ESTNewsAkero's liver disease drug gets FDA breakthrough therapy tagN/A
2022-11-24 02:08 ESTNewsAkero Therapeutics: What Is Making The Stock TickN/A
2022-11-04 15:25 ESTNewsAkero Therapeutics GAAP EPS of -$0.92 misses by $0.20N/A
2022-10-25 22:18 ESTNewsAkero: Putting Together The Pieces They Let Us SeeN/A
2022-09-19 18:37 ESTNewsAkero Therapeutics announces closing of upsized public offeringN/A
2022-09-19 02:04 ESTNewsAkero Therapeutics: A Promising NASH InnovatorN/A
2022-09-16 05:21 ESTNewsAkero Therapeutics: Outstanding Data In NASHN/A
2022-09-15 11:26 ESTNewsAkero Therapeutics stock slides on pricing upsized ~$200.0M stock offeringN/A
2022-09-14 18:07 ESTNewsAkero Therapeutics' Positive NASH Trial Results And Cash RaiseN/A
2022-09-14 00:37 ESTNewsAkero stock soars 71% as drug improves liver fibrosis, prevents disease worsening in trialN/A
2022-09-14 00:36 ESTNewsAkero adds over 100% rallying peers after NASH successN/A
2022-09-14 00:36 ESTNewsAkero Therapeutics commences underwritten public offering of $175M of sharesN/A
2022-08-04 23:03 ESTNewsAkero Therapeutics GAAP EPS of -$0.77 beats by $0.10N/A
2022-06-16 14:38 ESTNewsPfizer makes $25M equity investment in AkeroN/A
2022-05-06 18:49 ESTNewsAkero Therapeutics GAAP EPS of -$0.74 beats by $0.07N/A
2022-02-25 22:21 ESTNewsAkero Therapeutics GAAP EPS of -$0.93 misses by $0.13N/A
2022-02-09 07:08 ESTNewsAkero finishes enrollment in phase 2b trial of efruxifermin in liver diseaseN/A
2022-01-12 18:10 ESTNewsAkero Therapeutics (AKRO) Presents At 40th Annual J.P. Morgan Virtual Healthcare ConferenceN/A
2022-01-12 18:10 ESTNewsAkero Therapeutics (AKRO) Investor Presentation - SlideshowN/A
2021-11-12 16:26 ESTNewsAkero Therapeutics EPS beats by $0.16N/A
2021-10-20 02:11 ESTNewsAkero nabs Fast Track designation for efruxifermin for NASHN/A
2021-10-12 20:08 ESTNewsWarning: AKRO is at high risk of performing badlyN/A
2021-10-07 04:15 ESTNewsAKRO is at high risk of performing badlyN/A
2021-09-27 12:22 ESTNewsWarning: AKRO has been downgraded to Very BearishN/A
2021-09-23 22:19 ESTNewsAkero: Ticking All The Right Boxes In NASHN/A
2021-09-22 20:56 ESTNewsWarning: AKRO has been downgraded to Very Bearish.N/A
2021-09-10 16:11 ESTNewsAkero initiated with a buy at BofA on underappreciated clinical profileN/A
2021-08-13 08:25 ESTNewsAkero Therapeutics EPS misses by $0.17N/A
2021-07-20 18:14 ESTNewsAkero Therapeutics' efruxifermin meets primary endpoint in mid-stage NASH trialN/A
2021-07-20 18:08 ESTNewsAkero Therapeutics adds Judy Chou to its board of directorsN/A
2021-04-21 13:38 ESTNews89bio could close the valuation gap with Akero by end of 2021: CantorN/A
2021-03-18 12:04 ESTAnalyst RatingThe Analyst Target Price has decreased from $59.5 to $58.75.Neutral
2021-03-17 20:05 ESTFinancialsCompany financials have been released.Neutral
2021-03-17 12:03 ESTEarnings EstimateAn EPS average of -$3.73 is estimated for the 2022 year.Sell
2021-03-17 12:03 ESTEarnings EstimateAn EPS average of -$0.80 is estimated for the quarter ending on June 30, 2021.Buy
2021-03-16 18:57 ESTNewsAkero Therapeutics EPS misses by $0.29N/A
2021-03-01 11:04 ESTAnalyst RatingThe Analyst Target Price has decreased from $60.29 to $59.5.Neutral
2020-12-13 03:07 ESTFinancialsCompany financials have been released.Neutral
2020-12-11 15:05 ESTFinancialsCompany financials have been released.Neutral
2020-11-25 11:09 ESTFinancialsCompany financials have been released.Neutral
2020-11-17 03:04 ESTFinancialsCompany financials have been released.Neutral

About Akero Therapeutics, Inc (AKRO):

Akero Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development and commercialization of treatments for serious metabolic diseases. Its lead product candidate is AKR-001, which is in Phase IIa clinical trial for the treatment of nonalcoholic steatohepatitis disease.The company was formerly known as Pippin Pharmaceuticals, Inc. and changed its name to Akero Therapeutics, Inc. in May 2018. Akero Therapeutics, Inc. was founded in 2017 and is headquartered in South San Francisco, California.

AKRO Quotes by TradingView

See Advanced Chart

General

  • Name Akero Therapeutics, Inc
  • Symbol AKRO
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 13
  • Fiscal Year EndDecember
  • IPO Date2019-06-20
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Web URLhttp://www.akerotx.com
View More

Valuation

  • Trailing PE 8.18
  • Price/Book (Most Recent Quarter) 4.38
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$3.88
  • Next Year EPS Estimate -$4.26
  • Next Quarter EPS Estimate -$0.55
  • Return on Assets -18%
  • Return on Equity -30%
  • Earnings Per Share -$91.75
  • Revenue Per Share $0
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 1.11 billion
  • Analyst Target Price $58.75
  • Book Value Per Share $8.25
View More

Share Statistics

  • Shares Outstanding 34.77 million
  • Shares Float 17.06 million
  • % Held by Insiders 840%
  • % Held by Institutions 93.8%
  • Shares Short 2.23 million
  • Shares Short Prior Month 2.13 million
  • Short Ratio 9.66
  • Short % of Float 12%
  • Short % of Shares Outstanding 6%
View More

Technicals

  • 52 Week High $41.16
  • 52 Week Low $15.02
  • 50 Day Moving Average 31.18
  • 200 Day Moving Average 29.64
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Akero Therapeutics, Inc (AKRO) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Akero Therapeutics, Inc (AKRO) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-16$N/A-$0.86-$0.59-45.76%
2020-09-302020-11-12$N/A-$0.63-$0.676.11%
2020-06-302020-08-12$N/A-$0.57-$0.627.72%
2020-03-312020-05-13$N/A-$0.42-$0.6131.15%
2019-12-312020-03-16$N/A-$0.55-$0.585.97%
2019-09-302019-11-12$N/A-$0.56-$0.43-30.69%
2019-06-302019-08-12$N/A-$0.26-$0.3628.51%

Akero Therapeutics, Inc (AKRO) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date Dec 31 2020 Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019
Research Development 25.71 million 17.38 million 13.04 million 8.79 million 13.14 million
Income Before Tax -29.71 million -21.4 million -16.21 million -11.89 million -15.61 million
Selling General Administrative 4.07 million 4.16 million 3.42 million 3.59 million 3.08 million
Gross Profit N/A N/A N/A N/A N/A
Ebit -29.77 million -21.54 million -16.45 million -12.38 million -16.22 million
Operating Income -29.78 million -21.54 million -16.45 million -12.38 million -16.22 million
Income Tax Expense N/A N/A N/A N/A N/A
Total Revenue N/A N/A N/A N/A N/A
Cost of Revenue N/A N/A N/A N/A N/A
Total Other Income Expense Net 72000 N/A N/A N/A 610000
Net Income From Continuing Operations -29.71 million -21.4 million -16.21 million -11.89 million -15.61 million
Net Income Applicable to Common Shares -29.71 million -21.4 million -16.21 million N/A -15.61 million
Cash Flow:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Investments -59.84 million 38.47 million -6.28 million N/A N/A
Change to Liabilities 2.1 million 1 million N/A N/A -1.6 million
Total Cash Flow from Investing Activities -59.84 million 38.47 million N/A N/A N/A
Net Borrowings N/A N/A N/A N/A N/A
Total Cash Flow from Financial Activities 202.78 million 100000 164000 N/A -1.61 million
Change to Operating Activities 4.18 million -8.8 million N/A N/A 3.46 million
Change in Cash 129.43 million 15.98 million -17.43 million N/A -14.82 million
Total Cash from Operating Activities -13.51 million -22.58 million -11.32 million N/A -13.21 million
Depreciation N/A N/A N/A N/A N/A
Other Cash Flow from Investing Activities N/A N/A N/A N/A N/A
Change to Inventory N/A N/A N/A N/A N/A
Change to Account Receivables N/A N/A N/A N/A N/A
Other Cash Flow from Financing Activities 67000 -67000 N/A N/A N/A
Change to Net Income 1.61 million 1.42 million N/A N/A 483000
Capital Expenditures N/A N/A N/A N/A N/A
Balance Sheet:
Date Dec 31 2020 Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019
Total Liabailities 14.63 million 13.58 million 10.4 million 8.3 million 9.39 million
Total Stockholder Equity 258.71 million 286.46 million 103.66 million 118.32 million 128.73 million
Other Current Liabilities 13.11 million 126000 146000 126000 9.37 million
Total Assets 273.34 million 300.04 million 114.06 million 126.62 million 138.12 million
Common Stock 258.71 million 4000 3000 N/A 128.73 million
Other Current Assets 2.96 million N/A N/A N/A 1.65 million
Retained Earnings -209.53 million -179.82 million -158.41 million -142.21 million N/A
Other Liabilities N/A N/A 2000 N/A 23000
Other Assets 1.99 million 156000 865000 N/A 69000
Cash 187.24 million 192.68 million 63.25 million 47.25 million 136.4 million
Total Current Liabilities 13.11 million 12.01 million 10.39 million 8.29 million 9.37 million
Other Stockholder Equity N/A 16000 90000 N/A N/A
Property, Plant & Equipment N/A 1.85 million N/A N/A N/A
Total Current Assets 271.35 million 298.03 million 113.19 million 126.22 million 138.05 million
Long Term Investments N/A N/A N/A N/A N/A
Net Tangible Assets 258.71 million 286.46 million 103.66 million N/A 128.73 million
Short Term Investments 81.15 million 99.19 million 39.59 million 78.04 million N/A
Long Term Debt N/A N/A N/A N/A N/A
Inventory N/A N/A N/A N/A N/A
Accounts Payable 3.43 million 4.64 million 2.54 million 1.54 million N/A

Akero Therapeutics, Inc (AKRO) Chart:

Akero Therapeutics, Inc (AKRO) News:

Below you will find a list of latest news for Akero Therapeutics, Inc (AKRO) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Akero Therapeutics, Inc (AKRO) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-08-1512.50CALL0 0862.14TRUE00
2025-08-15150CALL0 3754.28TRUE00
2025-08-1517.50CALL0 0681.09TRUE00
2025-08-15200CALL0 0590.61TRUE00
2025-08-1522.50CALL0 0525.22TRUE00
2025-08-15250CALL0 0478.5TRUE00
2025-08-1527.523.45CALL0 4425.2TRUE00
2025-08-153023.3CALL0 37357.44TRUE00
2025-08-1532.521.16CALL0 2295.51TRUE00
2025-08-153516CALL0 56265.29TRUE00
2025-08-1537.50CALL0 3211.89TRUE00
2025-08-154013.47CALL0 621115.09TRUE00
2025-08-1542.512CALL0 237130.66TRUE00
2025-08-15456.3CALL4 842111.46TRUE-0.3-0.05
2025-08-1547.55.06CALL0 351120.75TRUE00
2025-08-15503.2CALL9 1708114.8TRUE-0.9-0.22
2025-08-1552.52.56CALL74 564132FALSE-0.34-0.12
2025-08-15551.85CALL532 5232136.37FALSE-0.85-0.31
2025-08-1557.51.39CALL4 544143.14FALSE-0.24-0.15
2025-08-15600.95CALL9 2566143.71FALSE-0.35-0.27
2025-08-1562.51.07CALL0 248151.56FALSE00
2025-08-15650.55CALL16 435155.04FALSE-0.22-0.29
2025-08-15700.4CALL0 445169.55FALSE00
2025-08-15750CALL0 5195.49FALSE00
2025-08-15800.21CALL0 274218.94FALSE00
2025-08-15850CALL0 1305FALSE00
2025-08-1512.50PUT0 1576.25FALSE00
2025-08-15150PUT0 0567.05FALSE00
2025-08-1517.50PUT0 0499.78FALSE00
2025-08-15200PUT0 0442.1FALSE00
2025-08-1522.50PUT0 0391.53FALSE00
2025-08-15250.3PUT0 1346.41FALSE00
2025-08-1527.50PUT0 0305.55FALSE00
2025-08-15300PUT0 29268.1FALSE00
2025-08-1532.50PUT0 4233.38FALSE00
2025-08-15350.05PUT11 79137.22FALSE0.050
2025-08-1537.50.78PUT0 186170.14FALSE00
2025-08-15402.25PUT0 452132.81FALSE00
2025-08-1542.50.35PUT100 458110.04FALSE-0.15-0.3
2025-08-15450.85PUT23 3391113.8FALSE-1.29-0.6
2025-08-1547.51.8PUT6 581122.59FALSE-0.2-0.1
2025-08-15503.7PUT9 989126.28FALSE0.420.13
2025-08-1552.54.71PUT10 273115.66TRUE-0.07-0.01
2025-08-15556.7PUT2 255131.93TRUE0.080.01
2025-08-1557.57.1PUT0 77154.88TRUE00
2025-08-15600PUT0 17154.22TRUE00
2025-08-1562.50PUT0 0177.69TRUE00
2025-08-156513.32PUT0 155169.15TRUE00
2025-08-157020.84PUT0 1189.71TRUE00
2025-08-15750PUT0 0280.54TRUE00
2025-08-15800PUT0 0193.53TRUE00
2025-08-15850PUT0 0203.15TRUE00
2025-09-19250CALL0 0170.14TRUE00
2025-09-1927.50CALL0 0158.87TRUE00
2025-09-19300CALL0 0136.5TRUE00
2025-09-1932.50CALL0 0123.1TRUE00
2025-09-19350CALL0 055.07TRUE00
2025-09-1937.50CALL0 049.83TRUE00
2025-09-194013.8CALL0 151.06TRUE00
2025-09-1942.50CALL0 069.31TRUE00
2025-09-19457.8CALL1 2569.07TRUE7.80
2025-09-1947.55.6CALL0 10376.59TRUE00
2025-09-19505.4CALL2 40975.38TRUE-1-0.16
2025-09-1952.54.6CALL21 28179.51FALSE-0.67-0.13
2025-09-19553.7CALL81 553779.55FALSE-0.44-0.11
2025-09-1957.53CALL10 4380.32FALSE-0.9-0.23
2025-09-19602.1CALL11 55082.28FALSE-0.66-0.24
2025-09-19651.55CALL12 21081.82FALSE-0.11-0.07
2025-09-19701CALL0 1386.03FALSE00
2025-09-19750.36CALL0 3983.4FALSE00
2025-09-19800.8CALL0 183.16FALSE00
2025-09-19250PUT0 0133.18FALSE00
2025-09-1927.50PUT0 0117.55FALSE00
2025-09-19300PUT0 0103.22FALSE00
2025-09-1932.50PUT0 089.95FALSE00
2025-09-19350PUT0 077.52FALSE00
2025-09-1937.50.45PUT0 170.93FALSE00
2025-09-19401PUT11 173.92FALSE-0.06-0.06
2025-09-1942.51.5PUT1 2571.87FALSE1.50
2025-09-19452.35PUT101 3073.17FALSE-0.15-0.06
2025-09-1947.54.7PUT0 5975.58FALSE00
2025-09-19503.8PUT0 12277.55FALSE00
2025-09-1952.57.5PUT0 4878.77TRUE00
2025-09-19558.2PUT0 5380.39TRUE00
2025-09-1957.510PUT0 578.9TRUE00
2025-09-196011.8PUT0 484.15TRUE00
2025-09-196514.6PUT0 192.68TRUE00
2025-09-19700PUT0 094.98TRUE00
2025-09-19750PUT0 090.54TRUE00
2025-09-19800PUT0 082.86TRUE00
2025-11-21200CALL0 0145.74TRUE00
2025-11-2122.50CALL0 070.53TRUE00
2025-11-212523.95CALL0 1102.12TRUE00
2025-11-2127.50CALL0 0100.75TRUE00
2025-11-213023.8CALL0 367.42TRUE00
2025-11-2132.50CALL0 061.14TRUE00
2025-11-21350CALL0 065.15TRUE00
2025-11-2137.50CALL0 062.73TRUE00
2025-11-214013.6CALL0 2568.71TRUE00
2025-11-2142.511.7CALL0 1065.97TRUE00
2025-11-214513CALL0 31966.96TRUE00
2025-11-2147.59.4CALL0 5967.29TRUE00
2025-11-21508.6CALL0 26769.08TRUE00
2025-11-2152.55.32CALL0 8267.63FALSE00
2025-11-21555.87CALL0 10366.46FALSE00
2025-11-2157.54.9CALL1 515267.47FALSE-0.1-0.02
2025-11-21604.25CALL7 3967.99FALSE-0.11-0.03
2025-11-2162.53.34CALL26 5165FALSE0.130.04
2025-11-21652.99CALL0 10764.2FALSE00
2025-11-21701.04CALL0 158460.8FALSE00
2025-11-21751.05CALL0 13659.73FALSE00
2025-11-21800.45CALL1 4853.61FALSE0.450
2025-11-21200PUT0 0107.3FALSE00
2025-11-2122.50PUT0 095.15FALSE00
2025-11-21250PUT0 084.31FALSE00
2025-11-2127.50PUT0 074.5FALSE00
2025-11-21300PUT0 769.19FALSE00
2025-11-2132.52.45PUT0 3170.09FALSE00
2025-11-21350PUT0 3069.72FALSE00
2025-11-2137.52.22PUT0 9869.73FALSE00
2025-11-21402.73PUT0 4571.46FALSE00
2025-11-2142.52.65PUT0 1568.14FALSE00
2025-11-21454.1PUT0 34069.43FALSE00
2025-11-2147.54.8PUT0 6669.31FALSE00
2025-11-21507PUT6 6570.72FALSE70
2025-11-2152.56.7PUT0 2969.41TRUE00
2025-11-21559.4PUT0 14368.83TRUE00
2025-11-2157.510.16PUT0 5966.21TRUE00
2025-11-216012.3PUT0 14267.29TRUE00
2025-11-2162.511.9PUT0 3665.93TRUE00
2025-11-216514.8PUT0 1064.55TRUE00
2025-11-21700PUT0 061.95TRUE00
2025-11-21750PUT0 063.97TRUE00
2025-11-21800PUT0 069.26TRUE00
2026-01-162.50CALL0 0405.3TRUE00
2026-01-1650CALL0 0284.72TRUE00
2026-01-167.50CALL0 0230.91TRUE00
2026-01-16100CALL0 0192.11TRUE00
2026-01-1612.50CALL0 4164.01TRUE00
2026-01-16150CALL0 1149.12TRUE00
2026-01-1617.50CALL0 69136.41TRUE00
2026-01-162032CALL0 10122.68TRUE00
2026-01-1622.50CALL0 1062.65TRUE00
2026-01-162525.5CALL0 2688.9TRUE00
2026-01-1627.521.8CALL0 2160.66TRUE00
2026-01-163026.2CALL0 27161.68TRUE00
2026-01-1632.50CALL0 1664.72TRUE00
2026-01-163521.11CALL0 1766.24TRUE00
2026-01-1637.519.38CALL0 6058.57TRUE00
2026-01-164018.7CALL0 5862.03TRUE00
2026-01-1642.516.83CALL0 10561.98TRUE00
2026-01-164514.84CALL0 5662.94TRUE00
2026-01-1647.512.1CALL0 94563.93TRUE00
2026-01-16509.01CALL1 2563.56TRUE9.010
2026-01-1652.57.75CALL2 1461.82FALSE-0.3-0.04
2026-01-16557.13CALL0 6558.26FALSE00
2026-01-1657.55.5CALL0 2957.68FALSE00
2026-01-16605.5CALL0 4455.93FALSE00
2026-01-1662.53.7CALL0 453.75FALSE00
2026-01-16652.35CALL0 13055.7FALSE00
2026-01-16701.05CALL0 6450.44FALSE00
2026-01-16751.05CALL0 2649.49FALSE00
2026-01-16800.75CALL6 32048.12FALSE-0.25-0.25
2026-01-16850.4CALL0 753.91FALSE00
2026-01-162.50PUT0 0223.26FALSE00
2026-01-1650PUT0 15151.91FALSE00
2026-01-167.50PUT0 0172.91FALSE00
2026-01-16100PUT0 0146.6FALSE00
2026-01-1612.50PUT0 15126.93FALSE00
2026-01-16150PUT0 0111.25FALSE00
2026-01-1617.50PUT0 298.2FALSE00
2026-01-16200.05PUT0 16987.02FALSE00
2026-01-1622.50PUT0 177.22FALSE00
2026-01-16250.38PUT0 5670.36FALSE00
2026-01-1627.50.75PUT0 166.85FALSE00
2026-01-16301.05PUT0 4467.05FALSE00
2026-01-1632.50PUT0 066.96FALSE00
2026-01-16352.05PUT0 3065.57FALSE00
2026-01-1637.52.61PUT0 564.53FALSE00
2026-01-16403.7PUT0 21366.99FALSE00
2026-01-1642.54.4PUT0 4266.34FALSE00
2026-01-16455.1PUT0 1665.54FALSE00
2026-01-1647.55.3PUT0 363.81FALSE00
2026-01-16506.84PUT0 2062.05FALSE00
2026-01-1652.50PUT0 063.66TRUE00
2026-01-16550PUT0 063.26TRUE00
2026-01-1657.50PUT0 060.2TRUE00
2026-01-166013.2PUT0 1357.05TRUE00
2026-01-1662.50PUT0 057.79TRUE00
2026-01-16650PUT0 057.44TRUE00
2026-01-16700PUT0 253.34TRUE00
2026-01-16750PUT0 052.98TRUE00
2026-01-16800PUT0 055.84TRUE00
2026-01-16850PUT0 049.53TRUE00
2026-02-20250CALL0 066.23TRUE00
2026-02-2027.50CALL0 053.97TRUE00
2026-02-20300CALL0 065.83TRUE00
2026-02-2032.50CALL0 066.22TRUE00
2026-02-20350CALL0 061.46TRUE00
2026-02-2037.50CALL0 062.95TRUE00
2026-02-20400CALL0 062.91TRUE00
2026-02-2042.50CALL0 065.18TRUE00
2026-02-20450CALL0 063.44TRUE00
2026-02-2047.50CALL0 061.42TRUE00
2026-02-20509.18CALL0 159.49TRUE00
2026-02-2052.50CALL0 060.36FALSE00
2026-02-20559.8CALL0 158.47FALSE00
2026-02-2057.58.5CALL0 257.98FALSE00
2026-02-20600CALL0 054.46FALSE00
2026-02-2062.50CALL0 053.38FALSE00
2026-02-20655.9CALL0 853.84FALSE00
2026-02-20700CALL0 049.13FALSE00
2026-02-20750CALL0 046.72FALSE00
2026-02-20801.3CALL0 450.3FALSE00
2026-02-20250PUT0 062.26FALSE00
2026-02-2027.50PUT0 063.28FALSE00
2026-02-20300PUT0 061.94FALSE00
2026-02-2032.50PUT0 064.57FALSE00
2026-02-20352.3PUT0 165.73FALSE00
2026-02-2037.50PUT0 065.55FALSE00
2026-02-20400PUT0 064.72FALSE00
2026-02-2042.50PUT0 063.01FALSE00
2026-02-20454.9PUT0 864.08FALSE00
2026-02-2047.50PUT0 060.84FALSE00
2026-02-20508.5PUT0 861.3FALSE00
2026-02-2052.50PUT0 060.28TRUE00
2026-02-20550PUT0 058.58TRUE00
2026-02-2057.50PUT0 057.92TRUE00
2026-02-20600PUT0 058.32TRUE00
2026-02-2062.50PUT0 055.99TRUE00
2026-02-20650PUT0 052.84TRUE00
2026-02-20700PUT0 054.2TRUE00
2026-02-20750PUT0 050.28TRUE00
2026-02-20800PUT0 053.21TRUE00

Latest AKRO Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST22$8.07
Jun 13, 2022 7:59 PM EST11$8.07
Jun 13, 2022 7:59 PM EST14$8.06
Jun 13, 2022 7:59 PM EST10$8.07
Jun 13, 2022 7:59 PM EST47$8.07

Akero Therapeutics, Inc (AKRO) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-01S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1744659/000110465920079692/0001104659-20-079692-index.htm
2020-05-20UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1744659/000000000020004520/0000000000-20-004520-index.htm
2020-07-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000090514820000773/0000905148-20-000773-index.htm
2020-07-08SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1744659/000090514820000781/0000905148-20-000781-index.htm
2020-09-09SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1744659/000090514820001009/0000905148-20-001009-index.htm
2020-05-15DRSDraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1744659/000091205720000169/0000912057-20-000169-index.htm
2020-01-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000101297520000013/0001012975-20-000013-index.htm
2020-01-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000101297520000022/0001012975-20-000022-index.htm
2020-01-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000101297520000029/0001012975-20-000029-index.htm
2020-01-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000101297520000033/0001012975-20-000033-index.htm
2020-02-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000101297520000113/0001012975-20-000113-index.htm
2020-02-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000101297520000115/0001012975-20-000115-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000101297520000119/0001012975-20-000119-index.htm
2020-02-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000101297520000267/0001012975-20-000267-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000101297520000275/0001012975-20-000275-index.htm
2020-03-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000101297520000291/0001012975-20-000291-index.htm
2020-07-06S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1744659/000104746920003964/0001047469-20-003964-index.htm
2020-07-09424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1744659/000104746920004044/0001047469-20-004044-index.htm
2020-09-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1744659/000108514620002410/0001085146-20-002410-index.htm
2020-01-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920001732/0001104659-20-001732-index.htm
2020-01-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920002773/0001104659-20-002773-index.htm
2020-01-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920003136/0001104659-20-003136-index.htm
2020-01-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1744659/000110465920003240/0001104659-20-003240-index.htm
2020-01-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920004440/0001104659-20-004440-index.htm
2020-01-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920005671/0001104659-20-005671-index.htm
2020-02-13SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920020276/0001104659-20-020276-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920021077/0001104659-20-021077-index.htm
2020-02-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1744659/000110465920025042/0001104659-20-025042-index.htm
2020-03-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920033412/0001104659-20-033412-index.htm
2020-03-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1744659/000110465920033680/0001104659-20-033680-index.htm
2020-03-16S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920034183/0001104659-20-034183-index.htm
2020-03-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920034208/0001104659-20-034208-index.htm
2020-03-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1744659/000110465920040850/0001104659-20-040850-index.htm
2020-04-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920042006/0001104659-20-042006-index.htm
2020-04-27DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920051294/0001104659-20-051294-index.htm
2020-05-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1744659/000110465920060866/0001104659-20-060866-index.htm
2020-05-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1744659/000110465920066655/0001104659-20-066655-index.htm
2020-06-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1744659/000110465920068978/0001104659-20-068978-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920069071/0001104659-20-069071-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920069072/0001104659-20-069072-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920069074/0001104659-20-069074-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920069075/0001104659-20-069075-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920069077/0001104659-20-069077-index.htm
2020-06-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1744659/000110465920071713/0001104659-20-071713-index.htm
2020-06-113Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920072520/0001104659-20-072520-index.htm
2020-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920072521/0001104659-20-072521-index.htm
2020-06-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1744659/000110465920074004/0001104659-20-074004-index.htm
2020-06-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1744659/000110465920078983/0001104659-20-078983-index.htm
2020-07-01S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1744659/000110465920079692/0001104659-20-079692-index.htm
2020-07-06CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1744659/000110465920080872/0001104659-20-080872-index.htm
2020-07-06CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1744659/000110465920080873/0001104659-20-080873-index.htm
2020-07-078-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1744659/000110465920081704/0001104659-20-081704-index.htm
2020-07-07S-1MEFRegistration adding securities to prior Form S-1 registration [Rule 462(b)]https://www.sec.gov/Archives/edgar/data/1744659/000110465920081820/0001104659-20-081820-index.htm
2020-07-104/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920082854/0001104659-20-082854-index.htm
2020-07-104/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920082855/0001104659-20-082855-index.htm
2020-07-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920083453/0001104659-20-083453-index.htm
2020-07-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920083455/0001104659-20-083455-index.htm
2020-08-07RWRegistration Withdrawal Requesthttps://www.sec.gov/Archives/edgar/data/1744659/000110465920092022/0001104659-20-092022-index.htm
2020-08-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1744659/000110465920093910/0001104659-20-093910-index.htm
2020-10-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1744659/000110465920115114/0001104659-20-115114-index.htm
2020-01-15SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1744659/000119312520008095/0001193125-20-008095-index.htm
2020-02-10SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1744659/000119312520028593/0001193125-20-028593-index.htm
2020-07-14SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1744659/000119312520192675/0001193125-20-192675-index.htm
2020-02-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000120919120008127/0001209191-20-008127-index.htm
2020-10-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000120919120054791/0001209191-20-054791-index.htm
2020-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1744659/000127417320000103/0001274173-20-000103-index.htm
2020-03-1610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1744659/000155837020002798/0001558370-20-002798-index.htm
2020-05-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1744659/000155837020006498/0001558370-20-006498-index.htm
2020-08-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1744659/000155837020010443/0001558370-20-010443-index.htm
2020-07-07EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1744659/999999999520001708/9999999995-20-001708-index.htm

Akero Therapeutics, Inc (AKRO) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Akero Therapeutics, Inc (AKRO). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 840%
Institutional Ownership: 9380%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-10-09Kevin BittermanDirectorSell13,000.0028.93376,090.0011,780.00https://www.sec.gov/Archives/edgar/data/1744659/000120919120054791/0001209191-20-054791-index.htm
2020-03-13Jonathan YoungChief Operating OfficerBuy5,035.000.623,096.53177,518.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920034208/0001104659-20-034208-index.htm
2020-03-13Jonathan YoungChief Operating OfficerBuy6,082.000.623,740.43183,600.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920034208/0001104659-20-034208-index.htm
2020-01-10Jonathan YoungChief Operating OfficerBuy17,621.000.6210,836.92211,197.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920003136/0001104659-20-003136-index.htm
2020-03-30G. Walmsley GrahamDirectorBuy2,168.0019.9743,294.962,168.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920042006/0001104659-20-042006-index.htm
2020-03-12Timothy RolphChief Scientific OfficerBuy27,368.000.6116,694.48220,277.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920033412/0001104659-20-033412-index.htm
2020-01-10Jonathan YoungChief Operating OfficerBuy21,286.000.6213,090.89232,483.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920003136/0001104659-20-003136-index.htm
2020-03-12Timothy RolphChief Scientific OfficerBuy22,656.000.6113,820.16242,933.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920033412/0001104659-20-033412-index.htm
2020-07-06Global Strategic Fund II L.P. venBio10% Share HolderSell4,603.0033.83155,721.333,033,552.00https://www.sec.gov/Archives/edgar/data/1744659/000090514820000773/0000905148-20-000773-index.htm
2020-07-02Global Strategic Fund II L.P. venBio10% Share HolderSell3,800.0033.63127,805.403,038,155.00https://www.sec.gov/Archives/edgar/data/1744659/000090514820000773/0000905148-20-000773-index.htm
2020-07-01Global Strategic Fund II L.P. venBio10% Share HolderSell108,064.0034.453,723,010.123,041,955.00https://www.sec.gov/Archives/edgar/data/1744659/000090514820000773/0000905148-20-000773-index.htm
2020-01-21Versant Venture Capital VI, L.P.10% Share HolderSell17,849.0022.39399,639.113,092,698.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920005671/0001104659-20-005671-index.htm
2020-01-21Versant Venture Capital VI, L.P.10% Share HolderSell8,091.0021.78176,221.983,110,547.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920005671/0001104659-20-005671-index.htm
2020-01-17Versant Venture Capital VI, L.P.10% Share HolderSell11,103.0020.09223,059.273,118,638.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920005671/0001104659-20-005671-index.htm
2020-01-16Versant Venture Capital VI, L.P.10% Share HolderSell22,489.0019.72443,483.083,129,741.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920005671/0001104659-20-005671-index.htm
2020-03-06Global Strategic Fund II L.P. venBio10% Share HolderSell1,800.0023.7942,830.823,150,019.00https://www.sec.gov/Archives/edgar/data/1744659/000101297520000291/0001012975-20-000291-index.htm
2020-03-05Global Strategic Fund II L.P. venBio10% Share HolderSell8,500.0023.53200,010.953,151,819.00https://www.sec.gov/Archives/edgar/data/1744659/000101297520000291/0001012975-20-000291-index.htm
2020-01-15Versant Venture Capital VI, L.P.10% Share HolderSell7,511.0019.73148,192.033,152,230.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920004440/0001104659-20-004440-index.htm
2020-01-14Versant Venture Capital VI, L.P.10% Share HolderSell12,307.0020.00246,140.003,159,741.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920004440/0001104659-20-004440-index.htm
2020-03-04Global Strategic Fund II L.P. venBio10% Share HolderSell35,650.0023.81848,765.903,160,319.00https://www.sec.gov/Archives/edgar/data/1744659/000101297520000291/0001012975-20-000291-index.htm
2020-01-13Versant Venture Capital VI, L.P.10% Share HolderSell83.0020.841,729.723,172,048.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920004440/0001104659-20-004440-index.htm
2020-01-13Versant Venture Capital VI, L.P.10% Share HolderSell11,593.0020.16233,714.883,172,131.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920004440/0001104659-20-004440-index.htm
2020-01-10Versant Venture Capital VI, L.P.10% Share HolderSell19,343.0020.10388,794.303,183,724.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920004440/0001104659-20-004440-index.htm
2020-03-03Global Strategic Fund II L.P. venBio10% Share HolderSell6,401.0023.00147,198.683,195,969.00https://www.sec.gov/Archives/edgar/data/1744659/000101297520000275/0001012975-20-000275-index.htm
2020-03-02Global Strategic Fund II L.P. venBio10% Share HolderSell10,297.0023.06237,459.123,202,370.00https://www.sec.gov/Archives/edgar/data/1744659/000101297520000275/0001012975-20-000275-index.htm
2020-01-09Versant Venture Capital VI, L.P.10% Share HolderSell16,527.0020.21334,010.673,203,067.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920002773/0001104659-20-002773-index.htm
2020-02-28Global Strategic Fund II L.P. venBio10% Share HolderSell5,100.0021.30108,652.443,212,667.00https://www.sec.gov/Archives/edgar/data/1744659/000101297520000275/0001012975-20-000275-index.htm
2020-01-08Versant Venture Capital VI, L.P.10% Share HolderSell22,368.0019.80442,886.403,219,594.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920002773/0001104659-20-002773-index.htm
2020-02-10Global Strategic Fund II L.P. venBio10% Share HolderSell7,836.0027.08212,168.323,225,861.00https://www.sec.gov/Archives/edgar/data/1744659/000101297520000119/0001012975-20-000119-index.htm
2020-02-27Global Strategic Fund II L.P. venBio10% Share HolderSell1,781.0022.5440,143.743,227,767.00https://www.sec.gov/Archives/edgar/data/1744659/000101297520000267/0001012975-20-000267-index.htm
2020-02-26Global Strategic Fund II L.P. venBio10% Share HolderSell2,523.0022.4456,615.363,229,548.00https://www.sec.gov/Archives/edgar/data/1744659/000101297520000267/0001012975-20-000267-index.htm
2020-02-25Global Strategic Fund II L.P. venBio10% Share HolderSell1,600.0023.6737,876.003,232,071.00https://www.sec.gov/Archives/edgar/data/1744659/000101297520000267/0001012975-20-000267-index.htm
2020-02-12Global Strategic Fund II L.P. venBio10% Share HolderSell6.0027.14162.843,233,671.00https://www.sec.gov/Archives/edgar/data/1744659/000101297520000119/0001012975-20-000119-index.htm
2020-02-11Global Strategic Fund II L.P. venBio10% Share HolderSell2,184.0027.0559,068.033,233,677.00https://www.sec.gov/Archives/edgar/data/1744659/000101297520000119/0001012975-20-000119-index.htm
2020-02-06Global Strategic Fund II L.P. venBio10% Share HolderSell6,102.0027.03164,954.763,233,697.00https://www.sec.gov/Archives/edgar/data/1744659/000101297520000115/0001012975-20-000115-index.htm
2020-02-05Global Strategic Fund II L.P. venBio10% Share HolderSell28,608.0025.99743,547.673,239,799.00https://www.sec.gov/Archives/edgar/data/1744659/000101297520000113/0001012975-20-000113-index.htm
2020-01-07Versant Venture Capital VI, L.P.10% Share HolderSell14,162.0020.05283,948.103,241,962.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920002773/0001104659-20-002773-index.htm
2020-01-06Versant Venture Capital VI, L.P.10% Share HolderSell42,323.0019.93843,497.393,256,124.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920001732/0001104659-20-001732-index.htm
2020-02-04Global Strategic Fund II L.P. venBio10% Share HolderSell53,731.0025.651,378,178.663,268,407.00https://www.sec.gov/Archives/edgar/data/1744659/000101297520000113/0001012975-20-000113-index.htm
2020-01-06Versant Venture Capital VI, L.P.10% Share HolderSell6,101.0018.32111,770.323,298,447.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920001732/0001104659-20-001732-index.htm
2020-01-06Versant Venture Capital VI, L.P.10% Share HolderSell4,968.0017.6887,834.243,304,548.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920001732/0001104659-20-001732-index.htm
2020-01-03Versant Venture Capital VI, L.P.10% Share HolderSell100.0020.272,027.003,309,516.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920001732/0001104659-20-001732-index.htm
2020-01-03Versant Venture Capital VI, L.P.10% Share HolderSell3,100.0019.1859,458.003,309,616.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920001732/0001104659-20-001732-index.htm
2020-01-13Global Strategic Fund II L.P. venBio10% Share HolderSell494,000.0020.239,993,620.003,322,138.00https://www.sec.gov/Archives/edgar/data/1744659/000101297520000033/0001012975-20-000033-index.htm
2020-01-08Global Strategic Fund II L.P. venBio10% Share HolderSell15,677.0019.86311,354.633,816,138.00https://www.sec.gov/Archives/edgar/data/1744659/000101297520000029/0001012975-20-000029-index.htm
2020-01-07Global Strategic Fund II L.P. venBio10% Share HolderSell31,000.0020.17625,149.103,831,815.00https://www.sec.gov/Archives/edgar/data/1744659/000101297520000022/0001012975-20-000022-index.htm
2020-01-06Global Strategic Fund II L.P. venBio10% Share HolderSell42,221.0019.64829,380.883,862,815.00https://www.sec.gov/Archives/edgar/data/1744659/000101297520000022/0001012975-20-000022-index.htm
2020-01-03Global Strategic Fund II L.P. venBio10% Share HolderSell12,498.0019.30241,213.903,905,036.00https://www.sec.gov/Archives/edgar/data/1744659/000101297520000013/0001012975-20-000013-index.htm
2020-01-02Global Strategic Fund II L.P. venBio10% Share HolderSell23,000.0019.94458,507.303,917,534.00https://www.sec.gov/Archives/edgar/data/1744659/000101297520000013/0001012975-20-000013-index.htm
2020-01-02Versant Venture Capital VI, L.P.10% Share HolderSell1,000.0022.1722,170.003,996,859.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920001732/0001104659-20-001732-index.htm
2020-01-02Versant Venture Capital VI, L.P.10% Share HolderSell3,900.0021.2082,680.003,997,859.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920001732/0001104659-20-001732-index.htm
2020-01-02Versant Venture Capital VI, L.P.10% Share HolderSell10,952.0019.89217,835.284,001,759.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920001732/0001104659-20-001732-index.htm
2020-07-10Apple Tree Partners IV, L.P.10% Share HolderBuy415,000.0036.0014,940,000.005,830,203.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920083455/0001104659-20-083455-index.htm
2020-07-10Seth Loring HarrisonDirectorBuy415,000.0036.0014,940,000.005,830,203.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920083453/0001104659-20-083453-index.htm